Product Pipeline

PTG-100: A GI-restricted α4β7 integrin-specific antagonist for the treatment of moderate-to-severe UC

PTG-200: A potential first-in-class oral IL-23R antagonist for the treatment of moderate-to-severe IBD

PTG-300: An Injectable hepcidin mimetic being developed to treat iron overload disorders